11/15/2026

Janusmed amning

Janusmed amning – Bunalict

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
1 1
1 1

Naloxon - peroral/sublingual

Naloxon - peroral/sublingual

Klass : 1

Visa all info

Skriv ut

Kontakta oss

  1. Jansson LM, McConnell K, Velez M, Spencer N, Gomonit M, Swortwood MJ. Buprenorphine-Naloxone Maintenance and Lactation. J Hum Lact. 2024;40(1):113-119.

  1. Jansson LM, McConnell K, Velez M, Spencer N, Gomonit M, Swortwood MJ. Buprenorphine-Naloxone Maintenance and Lactation. J Hum Lact. 2024;40(1):113-119.

Innehållet senast uppdaterat 11/3/2026

2 2
2 2

Buprenorfin

Buprenorfin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Grimm D, Pauly E, Pöschl J, Linderkamp O, Skopp G. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2005;27(4):526-30.

  2. Lindemalm S, Nydert P, Svensson JO, Stahle L, Sarman I. Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact. 2009;25:199-205.

  3. Ilett KF, Hackett LP, Gower S, Doherty DA, Hamilton D, Bartu AE. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Breastfeed Med. 2012;7:269-74.

  4. Marquet P, Chevrel J, Lavignasse P, Merle L, Lachâtre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997;62(5):569-71.

  5. Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM et al. Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001;63(1):97-103.

  6. Jansson LM, Spencer N, McConnell K, Velez M, Tuten M, Harrow CA et al. Maternal Buprenorphine Maintenance and Lactation. J Hum Lact. 2016;32:675-681.

  7. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction. 2003;98(1):103-10.

  8. Gower S, Bartu A, Ilett KF, Doherty D, McLaurin R, Hamilton D. The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age. J Hum Lact. 2014;30:217-23.

  9. Elladki H, Thill P. Buprenorphine withdrawal in an infant after cessation of breastfeeding: A case report and review of the literature. Pharmacotherapy. 2011;31(1):45e Abstract.

  10. Hirose M, Hosokawa T, Tanaka Y. Extradural buprenorphine suppresses breast feeding after cesarean section. Br J Anaesth. 1997;79:120-1

  11. Nelson-Rodriguez A, Saia K, Xie X, Momper J, Schiff DM, Wachman EM. Pharmacokinetics and Breast Milk Transfer to Infants of Subcutaneous Extended-Release Buprenorphine for the Treatment of Individuals with Opioid Use Disorder. Breastfeed Med. 2025;20(8):588-592.

  1. Grimm D, Pauly E, Pöschl J, Linderkamp O, Skopp G. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2005;27(4):526-30.
  2. Lindemalm S, Nydert P, Svensson JO, Stahle L, Sarman I. Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact. 2009;25:199-205.
  3. Ilett KF, Hackett LP, Gower S, Doherty DA, Hamilton D, Bartu AE. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Breastfeed Med. 2012;7:269-74.
  4. Marquet P, Chevrel J, Lavignasse P, Merle L, Lachâtre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997;62(5):569-71.
  5. Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM et al. Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001;63(1):97-103.
  6. Jansson LM, Spencer N, McConnell K, Velez M, Tuten M, Harrow CA et al. Maternal Buprenorphine Maintenance and Lactation. J Hum Lact. 2016;32:675-681.
  7. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction. 2003;98(1):103-10.
  8. Gower S, Bartu A, Ilett KF, Doherty D, McLaurin R, Hamilton D. The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age. J Hum Lact. 2014;30:217-23.
  9. Elladki H, Thill P. Buprenorphine withdrawal in an infant after cessation of breastfeeding: A case report and review of the literature. Pharmacotherapy. 2011;31(1):45e Abstract.
  10. Hirose M, Hosokawa T, Tanaka Y. Extradural buprenorphine suppresses breast feeding after cesarean section. Br J Anaesth. 1997;79:120-1
  11. Nelson-Rodriguez A, Saia K, Xie X, Momper J, Schiff DM, Wachman EM. Pharmacokinetics and Breast Milk Transfer to Infants of Subcutaneous Extended-Release Buprenorphine for the Treatment of Individuals with Opioid Use Disorder. Breastfeed Med. 2025;20(8):588-592.

Innehållet senast uppdaterat 11/3/2026